I Hate Dialysis Message Board
Welcome, Guest. Please login or register.
November 28, 2024, 11:36:22 AM

Login with username, password and session length
Search:     Advanced search
532606 Posts in 33561 Topics by 12678 Members
Latest Member: astrobridge
* Home Help Search Login Register
+  I Hate Dialysis Message Board
|-+  Dialysis Discussion
| |-+  Dialysis: News Articles
| | |-+  To Heal Diabetes, Doctors Push Weight-Loss Surgery - WSJ.com
0 Members and 1 Guest are viewing this topic. « previous next »
Pages: [1] Go Down Print
Author Topic: To Heal Diabetes, Doctors Push Weight-Loss Surgery - WSJ.com  (Read 1206 times)
okarol
Administrator
Member for Life
*****
Offline Offline

Gender: Female
Posts: 100933


Photo is Jenna - after Disneyland - 1988

WWW
« on: February 26, 2008, 03:30:17 PM »

To Heal Diabetes, Doctors Push Weight-Loss Surgery -WSJ.com

As of Wednesday, August 22, 2007     
Wall Street Journal

CONTROVERSIAL CARE
To Heal Diabetes, Doctors Push Weight-Loss Surgery
Studies Suggest Benefit For Bariatric Procedure;
Debate on Cost, Science

By RON WINSLOW
August 22, 2007; Page A1

Doctors who have turned surgery into a popular treatment for
obesity are setting their sights on a burgeoning new market:
diabetes patients.
A growing amount of research suggests that bariatric surgery,
which shrinks the stomach and sometimes reroutes the intestines,
has a lasting effect on the most common form of diabetes, and not
just because patients lose weight. Studies have found that more
than 75% of patients with this type of diabetes who undergo the
surgery see their disease disappear. They can go on to live
diabetes-free without insulin or other medicines.
Even advocates of bariatric surgery say it's too early to
recommend it for the broad mass of diabetics. Bariatric
surgery can lead to serious complications such as
nutritional deficiency. The death rate from the
procedure is estimated to be between one in 100 and one
in 1,000. An array of medicines, plus better diet
and exercise, can treat diabetes effectively without
invasive procedures.
Still, some doctors behind
the research believe surgery could be a new weapon against a
disease that affects some 20 million Americans and 250 million
people world-wide. "The idea that you could induce long-term
remission in diabetic patients without medication is
unprecedented," says Francesco Rubino, a surgeon at Catholic
University in Rome who is one of the leaders in the field. "Clearly
there's something big going on here that can't be ignored."
Studies into bariatric surgery's impact on diabetes are shedding
light on little-understood hormones that reside in the small
intestine and help keep the body's sugar levels in balance.
Researchers theorize that in diabetic patients, food causes these
hormones to go awry, but when surgery alters the intestinal tract
and diverts food away from them, the disease can quickly recede.
Understanding how this happens could lead to new medicines and
nonsurgical strategies to fight diabetes.
Bariatric surgery usually costs about $25,000 and is a big profit
center for some hospitals. If even a small percentage of diabetics
chose to undergo surgery, it would bring a gusher of new business
for the profession. Over the short term, at least, the cost of
surgery exceeds the estimated $10,000 a year needed for
conventional care of diabetics.
"As a primary treatment for diabetes, it simply doesn't measure up
very well," says Richard Hellman, president of the American
Association of Clinical Endocrinologists, specialists who treat
diabetes.
 
Treating Obesity
Bariatric surgery is currently recommended only for patients
considered "morbidly obese" -- those who are at least 100 pounds
overweight or about 75 pounds overweight and also have diabetes
or other related conditions. In medical parlance, this corresponds
to a body mass index, or BMI, of 40 and 35 respectively, according to a calculation based on
height and weight. Obesity is defined as a BMI of 30 or higher. A 5-foot-10-inch person who
weighs 245 pounds has a BMI of 35.
Health insurers generally cover bariatric surgery for the severely obese, though sometimes
reluctantly. It is unlikely that less-obese patients would receive broad coverage without a
significant body of research proving the surgery's benefits in such cases.
Death rates from bariatric surgery have fallen in recent years, partly reflecting new minimally
invasive techniques and efforts to improve quality. But a few patients still die on the operating
table or shortly afterward. Others suffer ill effects later, such as vitamin deficiency. Also, the
surgery isn't foolproof as a weight-loss strategy. Some patients gain lost weight back.
Daniel B. Jones, director of bariatric surgery at Beth Israel Deaconess Hospital in Boston, is
among doctors who think diabetics with moderate obesity may benefit from surgery. "If you have
type 2 diabetes and your BMI is 35, we absolutely intervene," says Dr. Jones, referring to the
more common type of diabetes that typically strikes adults. "Maybe we should be looking at
BMIs of 30. Maybe we're not being aggressive enough with the amount of health impact we can
have."
Barbara Brennan, who has diabetes, was more than 100 pounds overweight when Dr. Jones
operated on her July 2. Within a couple of weeks, she became light-headed and hadother signs of
low blood sugar. That is the reverse of the usual problem with diabetics, who experience high
blood sugar because their bodies aren't producing enough insulin or aren't properly using the
insulin that gets made. Ms. Brennan expects that she will soon be able to drop her diabetes
medicine. She has lost 34 pounds since the procedure.
"I can see the medical benefit already and it's not even two months," says the 60-year-old, who
retired as a property manager at Boston's Logan Airport. "Taking less medication plus having my
sugar levels being more stable has really made me feel a lot better."
However, she says, "I don't know if I'd ever recommend someone have the surgery just for
diabetes."
Last year, 177,600 patients underwent bariatric surgery,
according to the American Society of Bariatric Surgery,
nearly four times the figure five years earlier. Reflecting the
potential for growth from expanding the business to diabetes patients, the society plans to
announce today a name change to the American Society of Metabolic and Bariatric Surgery.
Following a meeting in Rome earlier this year, the society is part of an effort to publish a
consensus paper on when the surgery is appropriate in diabetes patients and what further research
needs to be done.
The prevalence of diabetes is growing at 5% a year, according to data from the U.S. Centers for
Disease Control and Prevention. Diabetics are at especially high risk for heart attacks as well as
such ailments as stroke, kidney disease, blindness, infertility and a clogging of blood vessels in
the legs and feet that can lead to amputations. Studies indicate that just 35% to 55% of diabetics
are able to keep their blood sugar under control. A treatment that could reduce this toll would be a
major advance and an economic boon to the health-care system.

Aggressive Marketing
Aggressive marketing and a gold-rush atmosphere sparked a surge in bariatric surgery for the
severely obese early in this decade, resulting in variable results for patients and a tarnished
reputation for the procedure.
"We don't want to make the same mistake twice," says Dr. Rubino, who will move from Rome in
October to head a new program for diabetes-surgery research at New York-Presbyterian
Hospital's Weill Cornell Medical Center in Manhattan. He says it could be a "disaster" if
thousands of patients were urged to get the procedure before further studies show who is likely to
get the most benefit from it.
Evidence of bariatric surgery's impact on diabetes has been building for two decades. In 1995,
Walter Pories, a surgeon at EastCarolina University, Greenville, N.C., and colleagues published a
paper in the Annals of Surgery titled, "Who Would Have Thought It?"
The report, based on 608 patients who had undergone the procedure over a 14-year period, found
not only weight loss but also long-term blood-sugar control in 83% of the patients who had
diabetes and 99% of patients with a prediabetic condition called glucose impairment. "No other
therapy has produced such durable and complete control of diabetes," the researchers reported.

'Radical Departure'
Few diabetes specialists noticed thearticle in the surgical journal. "It was such a radical departure
from how diabetes is treated, it didn't get much recognition by thought leaders in the diabetes
world," says Philip R. Schauer, head of bariatric surgery at the Cleveland Clinic.
In 2003, Dr. Schauer, then at the University of Pittsburgh, and colleagues reported in Annals of
Surgery on a five-year study of 1,160 diabetics who had the surgery. Their finding was nearly
identical: In 83% of the patients, blood sugar returned to normal, and it was markedly improved
in the others.
Results from both papers suggested patients with milder forms of diabetes and those who lost the
most weight after surgery were most likely to experience remission of the disease.
Recent papers point to another phenomenon. Among several variations of bariatric surgery, there
are two principal strategies. One of the strategies, marketed by Allergan Inc. and known as the
Lap-Band procedure, involves an adjustable band that iscinched around the stomach to reduce its
size. It is reversible and doesn't involve any rearrangement of the intestines.
The other strategy both shrinks the stomach and reroutes the passage of food to avoid upper
portions of the small intestine known as the duodenum and some of the jejunum. One specific
example of this strategy is a procedureknown as Roux-en-y gastric bypass.
Some doctors in the field say that although both forms of the surgery lead to weight loss, patients
who get the intestinal rerouting see faster improvement in their diabetes. That suggests weight
loss alone isn't a full explanation for how surgery might help diabetics.
 
Testing Surgery
While training as a surgeon at Mount Sinai Hospital in New York in the late 1990s, Dr. Rubino
became curious about whether surgery could address diabetes without shrinking the stomach. He
came up with a procedure that would bypass the duodenum and the upper portion of the jejunum
but leave the stomach intact, in contrast to the Roux-en-y procedure. Then he tested it on a strain
of laboratory rats that had type 2 diabetes but weren't obese. They were able to eat normally. The
procedure resulted in a dramatic reduction of diabetes. A report on the experiment was published
in the Annals of Surgery in 2004.
"That was the first evidence that the surgery could have a direct effect on diabetes that wasn't
related to losing weight," Dr. Rubino says.
Doctors are beginning to test the idea of intestines-only surgery in humans. Dr. Rubino says about
100 patients, all of them outside the U.S., have been treated with that approach, with encouraging
early results.
Fabrizio Michelassi, surgeon in chief at Weill Cornell, says such surgery could be a valuable
innovation. The standard forms of bariatric surgery typically leavepatients with stomachs the size
of an egg. "They are condemned to meals that are little purees for the rest of their lives," says Dr.
Michelassi. It may be, he says, that with Dr. Rubino's procedure, "you can still eat your steak and
potatoes and your diabetes gets controlled."
Other doctors say the stomach-reduction part of the traditional surgery plays an important role in
the antidiabetes effect. It may help by curtailing how quickly food flows into the intestine, they
say.
"It looks as if there are rogue cells in the intestine that are causing diabetes," says Dr. Pories, the
surgeon from East Carolina University. "The surgery either reduces the amount of food that
comes down to these cells or detours the food around them."

Studies Show Promise
Small studies of moderately obese diabetics in Brazil, India and Mexico show promise for
surgery, but the numbers are too small and the length of the studies too short to reach solid
conclusions.
Dr. Schauer at the Cleveland Clinic has started a five-year study of diabetics with BMIs ranging
from 30 to 40. Two groups of patients in the study will receive forms of bariatric surgery. A third
group will get only drugs and other noninvasive therapies. Dr. Schauer wants to discover which
group sees the greatest effect on diabetes.
"When you get a gastric bypass, things are dramatically changed in your favor," says Dr. Jones in
Boston. "We don't know what it is. We know it's real and it's reproducible. If we can tease it out,
it will be a huge advance."

Write to Ron Winslow at ron.winslow@wsj.com
To Heal Diabetes, Doctors Push Weight-Loss Surgery -WSJ.com
8/22/2007http://online.wsj.com/article/SB118774113343604709.html?mod=hps_us_pageone


My comment: This story has been referred to on the news lately so I have posted it here.
Logged


Admin for IHateDialysis 2008 - 2014, retired.
Jenna is our daughter, bad bladder damaged her kidneys.
Was on in-center hemodialysis 2003-2007.
7 yr transplant lost due to rejection.
She did PD Sept. 2013 - July 2017
Found a swap living donor using social media, friends, family.
New kidney in a paired donation swap July 26, 2017.
Her story ---> https://www.facebook.com/WantedKidneyDonor
Please watch her video: http://youtu.be/D9ZuVJ_s80Y
Living Donors Rock! http://www.livingdonorsonline.org -
News video: http://www.youtube.com/watch?v=J-7KvgQDWpU
Pages: [1] Go Up Print 
« previous next »
 

Powered by MySQL Powered by PHP SMF 2.0.17 | SMF © 2019, Simple Machines | Terms and Policies Valid XHTML 1.0! Valid CSS!